Clinical Trial Update: The Impact of Genetic Polymorphism on the Echocardiographic Parameters and Cardiac Fibrosis Markers in Response to Empagliflozin Treatment Among Patients With Heart Failure

View source ↗

Summary

This clinical trial update examines how genetic polymorphisms influence echocardiographic parameters and cardiac fibrosis markers in response to empagliflozin a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

Sponsor: Ain Shams University | Conditions: Heart Failure | Status: ACTIVE_NOT_RECRUITING